October 9, 2019
The wide range of capabilities at WDPrx ensure the proper resources in labor and equipment will be utilized for program success.
Every project is constantly evaluated against the highest benchmarks for key performance factors to ensure client satisfaction:
Clients rely on WDPrx to possess the required talent, technology and equipment to produce the desired results. At WDPrx, our on-site teams have decades of experience in every aspect of pharmaceutical development and manufacturing. The modern facility is designed for maximum flexibility, enabling decisions to be implemented quickly. All work procedures adhere to cGMP guidelines. WDPrx is licensed by the DEA to handle Controlled Substances (Schedules II-V) and possesses a Drug Establishment License issued by the FDA for manufacturing and packaging.
WDPrx operates in a collaborative environment that encourages open dialog among separate teams involved in the same work project. Often, new perspectives emerge that result in time and cost savings for the client. Our expertise empowers clients to determine their level of involvement in the process. Many choose to interact at every stage. Some prefer updates at regular intervals. In all cases, clients receive direct and immediate communication about project status, recommendations, feedback and analysis.
Effective CMO providers communicate equally well with clients and also with government and other regulatory authorities. WDPrx interacts effectively with governmental and other regulatory authorities is a benefit many clients find valuable when working with WDPrx. The experienced WDPrx technical team fosters professional relationships to assist when necessary that may help avoid delays and keep projects on track. The knowledge gained from the extensive WDPrx record of successful outcomes is applied to each project for the benefit of every client.
Pharmaceutical manufacturing requires a CMO to operate at high quality standards. Quality at WDPrx is an important investment in our people, technology and equipment.
Customer service is a vital component of overall quality at WDPrx. Client interaction and dialog is encouraged. Our streamlined management structure puts clients in direct communication with company decision-makers.
As an end-to-end provider managing development and manufacturing, WDPrx realizes the need for open lines of communication throughout the entire process to assure a successful outcome.
Successful outcomes at WDPrx extend to the efficient delivery of pharmaceutical drug products. Extensive on-site packaging and labeling operations follow cGMP guidelines and are DSCSA compliant. Primary packaging options include plastic and glass bottles and jars, nasal spray devices, metal and laminate tubes. Carton, tray and shrink-wrap are options for secondary packaging programs. WDPrx is equipped for delivery around the block and around the country to individuals, regional distribution centers and every point in between.
The experienced WDPrx clinical team also manages assembly and distribution of Pre-Clinical, Phase I and Late-Stage Clinical Trial materials combining kitting and labeling with tamper evident/child resistance requirements.
Contract manufacturing services create value for pharmaceutical manufacturers by eliminating the need to invest in new capacity required for production. WDPrx offers end-to-end CMO services with potential cost savings along the entire development and manufacturing chain from pharmaceutical formulation through production. WDPrx generates cost efficiencies through a combination of experienced professionals with a track record of success, modern equipment and the ability to research, develop, test, approve and manufacture drug products at our own FDA-approved laboratory facility.